Van Eis; Maurice
Patent Applications and Registrations
Patent applications and USPTO patent grants for Van Eis; Maurice.The latest application filed is for "bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk)".
- Van Eis; Maurice - St. Louis FR
- Van Eis; Maurice - Basel CH
- Van Eis; Maurice - Buschwiller FR
| Patent | Date |
|---|---|
| Bicyclic Heteroaryl Cycloalkyldiamine Derivatives As Inhibitors Of Spleen Tyrosine Kinases (syk) App 20160213670 - Buehlmayer; Peter ; et al. | 2016-07-28 |
| Bicyclic heteroaryl cycloalkyldiamine derivatives Grant 9,315,500 - Buehlmayer , et al. April 19, 2 | 2016-04-19 |
| Monocyclic heteroaryl cycloalkyldiamine derivatives Grant 9,290,481 - Smith , et al. March 22, 2 | 2016-03-22 |
| Bicyclic Heteroaryl Cycloalkyldiamine Derivatives App 20150218157 - Buehlmayer; Peter ; et al. | 2015-08-06 |
| Substituted indole derivatives Grant 9,029,396 - Cooke , et al. May 12, 2 | 2015-05-12 |
| Substituted Indole Derivatives App 20140179634 - COOKE; Nigel Graham ; et al. | 2014-06-26 |
| Indolylmaleimide derivatives processes for their production and pharmaceutical compositions Grant 8,742,132 - Van Eis , et al. June 3, 2 | 2014-06-03 |
| Substituted indole derivatives Grant 8,703,782 - Cooke , et al. April 22, 2 | 2014-04-22 |
| Monocyclic Heteroaryl Cycloalkyldiamine Derivatives App 20130310387 - Thoma; Gebhard ; et al. | 2013-11-21 |
| Substituted Indole Derivatives App 20130157980 - COOKE; Nigel Graham ; et al. | 2013-06-20 |
| Indolymaleimide derivatives Grant 8,426,440 - Wagner , et al. April 23, 2 | 2013-04-23 |
| 2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors Grant 8,283,356 - Baenteli , et al. October 9, 2 | 2012-10-09 |
| Indolylmaleimide Derivatives Processes For Their Production And Pharmaceutical Compositions App 20120219593 - VAN EIS; Maurice ; et al. | 2012-08-30 |
| Organic Compounds App 20120142685 - Dobler; Markus Rolf ; et al. | 2012-06-07 |
| Indolylmaleimide derivatives processes for their production and pharmaceutical compositions Grant 8,193,236 - van Eis , et al. June 5, 2 | 2012-06-05 |
| Substituted pyrrole-2, 5-diones as protein kinase C inhibitors Grant 7,851,475 - Van Eis , et al. December 14, 2 | 2010-12-14 |
| Indolymaleimide Derivatives App 20100273774 - Wagner; Jurgen ; et al. | 2010-10-28 |
| Indolylmaleimide derivatives Grant 7,781,438 - Wagner , et al. August 24, 2 | 2010-08-24 |
| 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors App 20100152182 - Baenteli; Rolf ; et al. | 2010-06-17 |
| 2, 6-naphthridine Derivatives App 20100130469 - van Eis; Maurice ; et al. | 2010-05-27 |
| Indolymaleimide derivatives Grant 7,691,861 - Van Eis , et al. April 6, 2 | 2010-04-06 |
| 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors Grant 7,671,063 - Baenteli , et al. March 2, 2 | 2010-03-02 |
| Indolylmaleimide Derivatives App 20100041693 - Van Eis; Maurice ; et al. | 2010-02-18 |
| Indolylmaleimide derivatives as PKC inhibitors Grant 7,648,989 - Van Eis , et al. January 19, 2 | 2010-01-19 |
| Substituted Pyrrole-2, 5-diones As Protein Kinase C Inhibitors App 20090221605 - Van Eis; Maurice ; et al. | 2009-09-03 |
| Indolylmaleimide Derivatives App 20080318975 - Wagner; Jurgen ; et al. | 2008-12-25 |
| Indolylmaleimide Derivatives as Pkc Inhibitors App 20080242675 - Van Eis; Maurice ; et al. | 2008-10-02 |
| Indolylmaleimide Derivatives App 20080234494 - Van Eis; Maurice ; et al. | 2008-09-25 |
| 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors App 20060247262 - Baenteli; Rolf ; et al. | 2006-11-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 